Valirx

(VAL)
Sector: Pharmaceuticals & Biotechnology
1.53p
0.00p 0.00
Last updated: 16:57:07

Company News Headlines

Date Time Headline Source
30/10/2024 07:00 Update on proposed sub-license of VAL201 RNS
18/10/2024 07:00 Directorate Change RNS
14/10/2024 07:00 Investor Webinar RNS
07/10/2024 07:00 Inaphaea Co-Marketing Agreement RNS
27/09/2024 07:00 Half-year Report RNS
26/09/2024 07:00 Conclusion of Evaluation Project RNS
24/09/2024 07:00 Inaphaea Co-Marketing Agreement RNS
18/09/2024 07:00 Inaphaea Evaluation and Commercial Use Agreement RNS
16/09/2024 07:00 Inaphaea Co-Marketing Agreement RNS
09/09/2024 07:00 Inaphaea Evaluation and Commercial Use Agreement RNS
09/09/2024 07:00 Investor Evening RNS
27/08/2024 07:00 Inaphaea Evaluation and Commercial Use Agreement RNS
12/08/2024 07:00 Directorate Change RNS
25/07/2024 07:00 Directorate Changes RNS
03/07/2024 08:51 Proposed Director Appointment RNS
20/06/2024 17:56 Result of AGM RNS
19/06/2024 11:33 Directorate Change RNS
17/06/2024 07:00 Inaphaea Contract Award RNS
28/05/2024 07:00 Investor Webinar RNS
20/05/2024 12:00 Business Update RNS
16/05/2024 07:00 Further re Final Results RNS
15/05/2024 07:00 Final Results and Notice of AGM RNS
22/04/2024 07:00 Directorate Changes RNS
21/03/2024 07:00 Evaluation Agreement with Imperial College London RNS
19/03/2024 07:00 Board Re-structuring and update on requisition RNS
04/03/2024 17:47 Shareholder Requisition Notice RNS
04/03/2024 07:00 Proposed Appointment of Non-Executive Director RNS
29/02/2024 14:00 Proposed Appointment of Non-Executive Director RNS
13/02/2024 14:20 Further re Shareholder Requisition Notice RNS
09/02/2024 17:06 Shareholder Requisition Notice RNS
19/01/2024 07:00 Change of Broker RNS
18/01/2024 07:00 Directorate Change RNS
04/01/2024 13:48 Result of GM, Issue of Equity RNS
19/12/2023 18:11 Result of Retail Offer, Subscription RNS
15/12/2023 07:00 Posting of Circular, Notice of GM and Ops Review RNS
13/12/2023 16:56 Retail Offer RNS
13/12/2023 16:49 Conditional Fundraise, Notice of General Meeting RNS
05/12/2023 07:00 Agreement to License VAL401 to Ambrose Healthcare RNS
10/11/2023 07:00 Evaluation Agreement with StingRay Bio RNS
06/10/2023 10:45 Statement re Share Price Movement RNS
28/09/2023 07:00 Operational Review RNS
24/08/2023 07:00 Half-year Report RNS
14/08/2023 07:00 Collaborative Services Agreement RNS
28/06/2023 14:15 Result of AGM RNS
16/06/2023 07:00 Conclusion of Hokkaido Evaluation Agreement RNS
14/06/2023 07:00 Asset Purchase – Imagen Therapeutics RNS
08/06/2023 07:00 Update on proposed sub-license of VAL201 RNS
07/06/2023 07:00 Expanded agreement with University of Barcelona RNS
05/06/2023 07:00 Final Results and Notice of AGM RNS
26/05/2023 07:00 Notice of Results and Investor Webinar RNS